Christian Schwabe

5.9k total citations
181 papers, 4.5k citations indexed

About

Christian Schwabe is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Occupational Therapy. According to data from OpenAlex, Christian Schwabe has authored 181 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Public Health, Environmental and Occupational Health, 31 papers in Molecular Biology and 30 papers in Occupational Therapy. Recurrent topics in Christian Schwabe's work include Pregnancy-related medical research (76 papers), Occupational Health and Performance (30 papers) and Hepatitis C virus research (25 papers). Christian Schwabe is often cited by papers focused on Pregnancy-related medical research (76 papers), Occupational Health and Performance (30 papers) and Hepatitis C virus research (25 papers). Christian Schwabe collaborates with scholars based in United States, New Zealand and Australia. Christian Schwabe's co-authors include Erika E. Büllesbach, E.E. Büllesbach, J. Ken McDonald, Bernard G. Steinetz, Edward Gane, Gillian D. Bryant‐Greenwood, Lloyd L. Anderson, P. Rod Dunbar, Anuj Gaggar and S. Bedarkar and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Christian Schwabe

175 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christian Schwabe United States 38 1.9k 875 785 712 478 181 4.5k
Simon C.M. Kwok United States 34 360 0.2× 299 0.3× 1.6k 2.1× 47 0.1× 130 0.3× 79 4.2k
Haiying Liu China 29 287 0.2× 909 1.0× 580 0.7× 150 0.2× 19 0.0× 97 3.5k
Bernard Ferruà France 31 665 0.3× 644 0.7× 746 1.0× 150 0.2× 5 0.0× 79 2.7k
W. Tony Parks United States 42 407 0.2× 589 0.7× 2.6k 3.3× 346 0.5× 4 0.0× 98 5.8k
Kai‐Hsin Lin Taiwan 35 628 0.3× 443 0.5× 827 1.1× 104 0.1× 5 0.0× 229 4.3k
Joyce Carlson Sweden 31 339 0.2× 488 0.6× 955 1.2× 133 0.2× 3 0.0× 47 3.9k
R. Chris Bleackley Canada 39 158 0.1× 1.1k 1.3× 2.2k 2.7× 50 0.1× 11 0.0× 68 5.0k
Tsai‐Ching Hsu Taiwan 44 304 0.2× 414 0.5× 3.2k 4.1× 131 0.2× 4 0.0× 238 6.7k
Susan E. Wilson United States 27 106 0.1× 332 0.4× 1.2k 1.5× 22 0.0× 39 0.1× 81 3.0k
George O. Gey United States 22 351 0.2× 218 0.2× 940 1.2× 52 0.1× 8 0.0× 45 2.9k

Countries citing papers authored by Christian Schwabe

Since Specialization
Citations

This map shows the geographic impact of Christian Schwabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Schwabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Schwabe more than expected).

Fields of papers citing papers by Christian Schwabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Schwabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Schwabe. The network helps show where Christian Schwabe may publish in the future.

Co-authorship network of co-authors of Christian Schwabe

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Schwabe. A scholar is included among the top collaborators of Christian Schwabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Schwabe. Christian Schwabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Geller, David E., et al.. (2024). WS10.03 Inhaled LUNAR®-CFTR mRNA (ARCT-032) is safe and well-tolerated: A phase 1 study. Journal of Cystic Fibrosis. 23. S19–S19. 7 indexed citations
3.
Dauki, Anees M., Nishanthan Rajakumaraswamy, Torsten Trowe, et al.. (2024). Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants. Clinical and Translational Science. 17(8). e70011–e70011. 1 indexed citations
4.
Pierson, Wim, Marianne Tuefferd, Florence Herschke, et al.. (2023). A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults. Antiviral Therapy. 28(3). 211898638–211898638.
5.
Hu, Yue, Edward Gane, Leen Slaets, et al.. (2023). Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral Therapy. 28(1). 211877386–211877386. 2 indexed citations
6.
Gane, Edward, Christian Schwabe, Luisa M. Stamm, et al.. (2023). The safety and pharmacokinetics of ABI-4334, a novel next-generation HBV core inhibitor: interim results from a phase 1 study in healthy volunteers. Journal of Hepatology. 78. S1161–S1162. 1 indexed citations
7.
Mak, Lung‐Yi, Ed Gane, Christian Schwabe, et al.. (2022). A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis. Journal of Hepatology. 78(4). 684–692. 52 indexed citations
8.
Yuen, Man‐Fung, Elina Berliba, Wattana Sukeepaisarnjaroen, et al.. (2022). Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B. Hepatology Communications. 6(12). 3457–3472. 17 indexed citations
10.
Yuen, Man‐Fung, Edward Gane, Dong Joon Kim, et al.. (2019). Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection. Gastroenterology. 156(5). 1392–1403.e7. 117 indexed citations
11.
Visvanathan, Sudha, Ulf Müller‐Ladner, Meera Ramanujam, et al.. (2019). Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study. Annals of the Rheumatic Diseases. 78(6). 754–760. 44 indexed citations
12.
13.
Steinetz, Bernard G., Alma J. Williams, George Lust, et al.. (2008). Transmission of relaxin and estrogens to suckling canine pups via milk and possible association with hip joint laxity. American Journal of Veterinary Research. 69(1). 59–67. 29 indexed citations
14.
Schwabe, Christian. (2004). Chemistry and Biodiversity. Chemistry & Biodiversity. 1(10). 1584–1587. 75 indexed citations
15.
Adham, Ibrahim M., et al.. (2002). The Overexpression of theInsl3in Female Mice Causes Descent of the Ovaries. Molecular Endocrinology. 16(2). 244–252. 109 indexed citations
16.
Büllesbach, Erika E. & Christian Schwabe. (2000). The Relaxin Receptor-binding Site Geometry Suggests a Novel Gripping Mode of Interaction. Journal of Biological Chemistry. 275(45). 35276–35280. 83 indexed citations
17.
Schwabe, Christian. (1990). The genomic potential hypothesis and phase-state mathematics. Computers & Mathematics with Applications. 20(4-6). 287–301. 4 indexed citations
18.
Schwabe, Christian, et al.. (1990). Relaxin, Oxytocin, and Prostaglandin Effects on Progesterone Secretion from Bovine Luteal Cells during Different Stages of Gestation. Experimental Biology and Medicine. 195(2). 255–260. 10 indexed citations
19.
Schwabe, Christian, et al.. (1986). Relaxin on Induction of Parturition in Beef Heifers*. Endocrinology. 118(4). 1476–1482. 30 indexed citations
20.
Schwabe, Christian & Gregory W. Warr. (1984). A Polyphyletic View of Evolution: The Genetic Potential Hypothesis. Perspectives in biology and medicine. 27(3). 465–485. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026